开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2023-09-20 ms7000000929368825 来自广东省

请问有收到让转投oral oncology reports的吗？这个好像没有影响因子

90 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2012-07-05 匿名用户

审稿速度:3.0 | 投稿命中率:25.0
经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。

486 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2020-08-01 paw2020

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：基础研究;头颈肿瘤
经验分享：刚中一篇，口腔癌基础研究，还挺开心的。
2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。

256 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2023-07-26 夜夜笙歌来自广西

偏重的研究方向：头颈肿瘤;肿瘤
经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果

123 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2023-10-10 零羚翎来自辽宁省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投

86 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2023-09-19 89413_0661 来自重庆

之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。

90 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2022-10-11 ms2000002115367694

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：口腔肿瘤
经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊

101 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2022-10-29 alanhuang

审稿速度:1.0 | 投稿命中率:50.0
经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。

103 0

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2022-03-24 1465389cm38暂无昵称

偏重的研究方向：头颈肿瘤;肿瘤
经验分享：Mar 23 required review completed

137 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158666, encodeId=73f12158666d9, content=请问有收到让转投oral oncology reports的吗？这个好像没有影响因子 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9d2e6448136, createdName=ms7000000929368825, createdTime=Wed Sep 20 10:09:27 CST 2023, time=2023-09-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=489453, encodeId=b5e6489453fd, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：杂志很好，头颈的基础的文章很难命中，仅仅5－7个实验满足不了基础方向编辑的胃口，临床方向结合基础，比较适合命中。文章的结果及讨论要求高，小修的意见中，提到数据问题，必须老实回答。对中国的研究数据稍微有点小疑问，但如实回答后，直接接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=486, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Thu Jul 05 12:36:00 CST 2012, time=2012-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805636, encodeId=72ef805636e4, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：基础研究;头颈肿瘤 经验分享：刚中一篇，口腔癌基础研究，还挺开心的。 2020.3.2投稿，2020.5.26返回审稿意见，两个审稿人意见都比较正面；第一个提了两个问题，第二个提了9个问题，一一回答。2020.7.2返回Revision，2020.7.28接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/k5r6L01rTcPlHwyibccFwVFY5Aib7fJfBU29SHsmayHSHM5jC1agLPRQ6fdKCNl7yEVupFdFBQo9NYd0icic5VcBpA/132, createdBy=2b365288508, createdName=paw2020, createdTime=Sat Aug 01 17:32:44 CST 2020, time=2020-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2149870, encodeId=de6721498e095, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：之前投放疗绿皮被拒，改天这个杂志，7-6号投稿，7-7 with editor，7-13 under review，送了2+个审稿人，其中两个审稿人接受审稿，7-17第一个审稿人完成审稿，7-25第二个审稿人完成审稿，目前是required reviews completed状态，希望有个好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221105/db51aaa37f00454f9e5581d89593ebdb/22150ba85da340dc920defe7c7296165.jpg, createdBy=9d6e5316077, createdName=夜夜笙歌, createdTime=Wed Jul 26 06:24:56 CST 2023, time=2023-07-26, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2162052, encodeId=c72d2162052b9, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：小白，来弱弱问一下，让转投成letter，不知道letter怎么样，值不值得投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/1103841572/1222E2BDEA9FA53BF39D328B2B4BFAD5/100, createdBy=f83a1998221, createdName=零羚翎, createdTime=Tue Oct 10 21:09:34 CST 2023, time=2023-10-10, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2158435, encodeId=a2f7215843518, content=之前投的放疗绿皮被拒了，绿皮外审后给了一些意见，按照给的意见一一修正后，改投oral oncology,2023.09.12投稿，09.13 状态with editor 09.18还是with editor,改了一个时间，期待好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34366219496, createdName=89413_0661, createdTime=Tue Sep 19 09:46:50 CST 2023, time=2023-09-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2093132, encodeId=5df4209313222, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：口腔肿瘤 经验分享：已经with editor一个月了还没有回复催了一次，不知道要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d6bf5509674, createdName=ms2000002115367694, createdTime=Tue Oct 11 15:40:58 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097361, encodeId=d5b6209e36193, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：OO官网自我介绍的录用率为22%，没有这里介绍的高。还有一个问题，我发现每一期article和letter的比例至少是1:1.5，甚至接近1:2，如果22%包括letter，那么article的录用率不到10%，有很多投稿是article而编辑要求改letter。中国大陆文章占20%稍多，估算下来一年中国发表40-50篇文章，自然是包括letter的，似乎也没想象中那么难。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eedb2029139, createdName=alanhuang, createdTime=Sat Oct 29 20:50:47 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205479, encodeId=f3e612054e923, content=偏重的研究方向：头颈肿瘤;肿瘤 经验分享：Mar 23 required review completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Thu Mar 24 09:34:55 CST 2022, time=2022-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222836, encodeId=e6c2122283646, content=May 24th Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Fri May 27 17:04:12 CST 2022, time=2022-05-27, status=1, ipAttribution=)]

2022-05-27 1465389cm38暂无昵称

May 24th Accept

106 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务